Firat D - Search Results

1

Acute tumor lysis syndrome following intrathecal methotrexate.

Benekli M, Güllü IH, Savaş MC, Kadayifçi A, Altundağ MK, Tekuzman G, Firat D. Benekli M, et al. Among authors: firat d. Leuk Lymphoma. 1996 Jul;22(3-4):361-3. doi: 10.3109/10428199609051770. Leuk Lymphoma. 1996. PMID: 8819088

2

Tumor lysis syndrome following single-dose mitoxantrone.

Benekli M, Savaş MC, Güllü IH, Kadayifçi A, Akpek G, Kars A, Güler N, Kansu E, Tekuzman G, Firat D. Benekli M, et al. Among authors: firat d. Chemotherapy. 1995 Nov-Dec;41(6):470-2. doi: 10.1159/000239384. Chemotherapy. 1995. PMID: 8529438

3

Dramatic response to ifosfamide, mesna and doxorubicin chemotherapy regimen in an adult with clear cell sarcoma of the kidney.

Yalçin S, Barişta I, Tekuzman G, Güllü I, Firat D. Yalçin S, et al. Among authors: firat d. J Urol. 1996 Jun;155(6):2024. J Urol. 1996. PMID: 8618315 No abstract available.

4

Procarbazine, CCNU, vincristine combination in the treatment of brain tumors.

Güllü IH, Celik I, Tekuzman G, Altunbaş M, Güler N, Barişta I, Alkiş N, Yalçin S, Kars A, Baltali E, Kansu E, Firat D. Güllü IH, et al. Among authors: firat d. Tumori. 1996 May-Jun;82(3):228-31. Tumori. 1996. PMID: 8693599

5

Ifosfamide, mesna and epirubicin as second-line chemotherapy in advanced breast cancer.

Kiraz S, Baltali E, Güler N, Barista I, Benekli M, Celik I, Güllü IH, Kars A, Tekuzman G, Firat D. Kiraz S, et al. Among authors: firat d. J Chemother. 1996 Aug;8(4):310-4. doi: 10.1179/joc.1996.8.4.310. J Chemother. 1996. PMID: 8873839 Clinical Trial.

6

Ifosfamide and etoposide in previously treated patients with advanced breast cancer.

Kiraz S, Baltali E, Güler N, Barişta I, Benekli M, Celik I, Güllü IH, Kars A, Tekuzman G, Firat D. Kiraz S, et al. Among authors: firat d. Tumori. 1997 Mar-Apr;83(2):604-7. doi: 10.1177/030089169708300225. Tumori. 1997. PMID: 9226029

7

Bolus and continuous infusion mitoxantrone in newly diagnosed adult acute lymphoblastic leukemia: results of two consecutive phase II clinical studies.

Koc Y, Akpek G, Kansu E, Kars A, Tekuzman G, Baltali E, Güler N, Barista I, Güllü I, Ozisik Y, Firat D. Koc Y, et al. Among authors: firat d. Cancer Invest. 1998;16(6):355-65. doi: 10.3109/07357909809115774. Cancer Invest. 1998. PMID: 9679525 Review.

8

VB-CHEP chemotherapy regimen for aggressive non-Hodgkin's lymphomas.

Yalçin S, Kars A, Ozişik Y, Tekuzman G, Ozyilkan O, Celik I, Barişta I, Güllü I, Güler N, Baltali E, Firat D. Yalçin S, et al. Among authors: firat d. Eur J Haematol. 1998 Oct;61(4):261-5. doi: 10.1111/j.1600-0609.1998.tb01712.x. Eur J Haematol. 1998. PMID: 9820633 Clinical Trial.

9

Paclitaxel and doxorubicin combination in the first-line treatment of metastatic breast cancer.

Baltali E, Altundağ MK, Güler N, Ozişik Y, Firat D, Baran I, Tekuzman G. Baltali E, et al. Among authors: firat d. Tumori. 2002 May-Jun;88(3):200-3. doi: 10.1177/030089160208800304. Tumori. 2002. PMID: 12195757 Clinical Trial.

10

Maintenance therapy with alpha-interferon following first-line VAD in multiple myeloma.

Kars A, Celik I, Kansu E, Tekuzman G, Ozişik Y, Güler N, Barişta I, Güllü I, Yalçin S, Altundağ K, Zengin N, Türker A, Hayran M, Baltali E, Firat D. Kars A, et al. Among authors: firat d. Eur J Haematol. 1997 Aug;59(2):100-4. doi: 10.1111/j.1600-0609.1997.tb00732.x. Eur J Haematol. 1997. PMID: 9293857 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119 results

Search Page

Filters